UnitedHealth (UNH) Insider John Noseworthy Buys 41 Shares

Insider Buying and Selling at UnitedHealth Group Incorporated

UnitedHealth Group Incorporated NYSE:UNH saw insider activity on June 23, 2026, when John Noseworthy bought 41 shares of the healthcare giant. While the transaction price was listed at $0.0, the move places additional shares in the hands of key personnel on the same day several other executives reported acquisitions.

Multiple Executives Add to Holdings

Several other leaders at UnitedHealth Group Incorporated also picked up shares on June 23, 2026. Chief Accounting Officer Stankiewicz Dennis Andrew acquired 51 shares, while Optum Chief Executive Officer Conway Patrick Hugh bought 83 shares. Additional purchases came from Noel Timothy John, Chief Executive Officer of UHC, who picked up 76 shares, alongside board-level buyers including Kristen Gil with 8 shares, Scott Gottlieb with 3 shares, and Montgomery Rice Valerie Md with 41 shares.

UnitedHealth Group Stock Trades Near Moving Averages

Shares of UnitedHealth Group Incorporated traded around $415.53, sitting comfortably above the 50-day moving average of $387.35 and the 200-day moving average of $358.75. The healthcare provider carries a market capitalization of $365.02 billion, with a P/E ratio of 26.15 and a forward P/E of 17.55. The stock has traded between a 52-week low of $255.97 and a 52-week high of $461.62.

Analysts Set New Price Targets

Wall Street firms have remained active in updating their views on UnitedHealth Group Incorporated. On October 16, 2026, Bernstein maintained its Outperform rating while lowering its price target to $500.0 from $512.0. On the same day, JP Morgan maintained an Overweight rating and raised its price target to $524.0 from $516.0. Earlier in October, TD Cowen reiterated a Hold rating at a $402.0 target, Piper Sandler maintained an Overweight rating with a $504.0 target, Barclays kept an Overweight rating at $440.0, and Baird maintained a Neutral rating with a $427.0 target. Overall, the stock holds a consensus recommendation of buy with 25 analyst opinions and a target mean price of $477.04.

Inside UnitedHealth Group Incorporated

UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States and internationally. It delivers patient care, wellness programs, and health financial services through Optum Health, offers software and consulting services through Optum Insight, and runs pharmacy care services through Optum Rx. Its UnitedHealthcare segment provides consumer-oriented health benefit plans and government-backed programs for individuals, employers, and economically disadvantaged groups.

What to Watch Next for the Stock

The cluster of insider purchases on June 23, 2026, highlights how corporate leaders manage their personal holdings alongside regular operations. Investors will look toward the company's next earnings report on January 26, 2027, for further details on financial performance and segment growth.